Clinical Trial Update: Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency [NA]

View source ↗

Summary

This clinical trial update indicates that autologous cultured corneal epithelium (CECA) is being studied for the treatment of limbal stem cell deficiency and is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limbal Stem Cell Deficiency

Drugs mentioned

• Autologous Cultured Corneal Epithelium (CECA)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Limbal Stem Cell Deficiency | NA | Status: RECRUITING